Cargando…
Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma
Background: The current study aimed to understand the genetic landscape and investigate the diagnostic and prognostic biomarkers of primary hepatocellular carcinoma (HCC). Methods: A cohort of 36 Chinese HCC samples with hepatitis B virus (HBV) infection was examined by whole-exome sequencing (WES)....
Autores principales: | Zhao, Yuanyuan, Yang, Bo, Chen, Dong, Zhou, Xiaojun, Wang, Meixi, Jiang, Jipin, Wei, Lai, Chen, Zhishui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906131/ https://www.ncbi.nlm.nih.gov/pubmed/33558447 http://dx.doi.org/10.18632/aging.202586 |
Ejemplares similares
-
Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020) -
LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
por: Liu, Ji, et al.
Publicado: (2020) -
Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022) -
ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Feng, Yuanyuan, et al.
Publicado: (2022) -
Loss of CSMD1 disrupts mammary epithelial morphogenesis
por: Kamal, M, et al.
Publicado: (2010)